RLMD NASDAQ
Relmada Therapeutics, Inc.
1W: -6.0%
1M: -20.7%
3M: -43.1%
YTD: -17.6%
1Y: +66.7%
3Y: +357.1%
5Y: -38.1%
$3.60
-0.06 (-1.64%)
Weekly Expected Move ±9.0%
$3
$3
$4
$4
$4
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$0M
Revenue
+0.0% YoY
$-62M
Net Income
+8.7% YoY
$-46M
Free Cash Flow
+7.9% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-55.7%
ROA-51.6%
ROIC460.5%
Valuation
P/E-3.9
P/B2.0
EV/EBITDA-9.0
Leverage
Debt/Equity0.00
Current Ratio29.52
Interest Cov.0.0x
Quality Scores
Piotroski F3/9
Altman Z32.88
Beneish M0.00